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Abstract. We have identified three DNase I-hypersen- 
sitive sites in chromatin between 15 and 17 kb upstream 
of the mouse proa2(I) collagen gene. These sites were 
detected in cells that produce type I collagen but not in 
cells that do not express these genes. A  construction 
containing the sequences from -17 kb to +54 bp of the 
mouse proa2(I) collagen gene, cloned upstream of ei- 
ther the Escherichia coli 13-galactosidase or the firefly 
luciferase reporter gene, showed strong enhancer activ- 
ity in transgenic mice when compared with the levels 
seen previously in animals harboring shorter promoter 
fragments. Especially high levels of expression of the 
reporter gene were seen in dermis, fascia, and the fi- 
brous layers of many internal organs. High levels of ex- 
pression could also be detected in some osteoblastic 
cells. When various fragments of the 5' flanking se- 
quences were cloned upstream of the 350-bp proximal 
proet2(I) collagen promoter linked to the lacZ gene, the 
cis-acting elements responsible for enhancement were 
localized in the region between -13.5 and -19.5 kb, 
the same region that contains the three DNase I-hyper- 
sensitive sites. Moreover, the DNA segment from 
-  13.5 to -  19.5 kb was also able to drive the cell-spe- 
cific expression of a 220-bp mouse proal(I) collagen 
promoter, which is silent in transgenic mice. Hence, our 
data suggest that a far-upstream enhancer element 
plays a role in regulating high levels of expression of 
the mouse pro~2(I) collagen gene. 
T 
HE genetic programs that control the differentiation 
of fibroblasts and osteoblasts are still poorly under- 
stood.  We  are  using the  type I  collagen  genes  as 
markers for these  cell lineages  to better understand  the 
mechanisms by which they express their phenotypes. The 
type I collagen genes are expressed at high levels in osteo- 
blasts, in odontoblasts, and in fibroblasts of tendons and 
skin, whereas in other tissues, their expression is consider- 
ably lower and is due mainly to the presence of fibroblasts 
and mesenchymal cells in these tissues. Type I collagen be- 
longs to the fibrillar class of collagens and is composed of 
two al(I) chains and one a2(I) chain (Cole,  1994; Phila- 
janiemi and Rehn, 1995, and references therein for review 
of collagen  types  and  functions).  Excessive  amounts  of 
these proteins along with other extracellular matrix pro- 
teins  are  found  in  fibrotic  diseases  including  cirrhosis, 
glomerulosclerosis, and scleroderma. 
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Transcription of the two genes for the type I  collagen 
polypeptides is coordinately regulated (Vuust et al., 1985), 
suggesting that similar transcriptional mechanisms proba- 
bly regulate both genes. Our long-term objective is to de- 
fine the sequence elements in the type I  collagen genes 
necessary for correct expression in different cell lineages 
and at various times in development and, subsequently, to 
identify the DNA-binding proteins that interact with these 
sequences. Earlier studies with transgenic mice, using pro- 
moter  sequences  of  the  mouse proa2(1)  collagen  gene 
from -2,000 to  +54 bp linked to a  CAT reporter gene, 
showed that CAT enzyme activity was present in many tis- 
sues  where  high  levels of the  endogenous gene  are  ex- 
pressed, such as tail, skin, and bone (Khillan et al., 1986). 
However, using CAT assays of tissue extracts, it was not 
possible  to  localize the  precise  cells  that  expressed  the 
transgene. Therefore, transgenic mice containing a 2,000- 
bp promoter linked to a lacZ reporter gene were gener- 
ated; these mice expressed the transgene in many cells that 
express the  corresponding endogenous gene  (Niederrei- 
ther et al., 1992). Similar qualitative results were obtained 
with  a  350-bp  protx2(I) collagen proximal promoter, ex- 
cept that the levels of expression were lower than with the 
2,000-bp promoter and expression in osteoblasts was  ei- 
ther absent or occurred at very low levels (D'Souza et al., 
1993). 
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transgenes were expressed in a specific manner and at the 
correct stage of development, the levels of expression of 
the reporter gene appeared to be lower than the levels of 
the endogenous gene, suggesting that additional important 
enhancer elements might be present in other parts of the 
gene.  Earlier  transient  expression  experiments in  tissue 
culture cells provided evidence for the presence of a tran- 
scriptional enhancer in the first intron between +418 and 
+1524  (Rossi  and  de  Crombrugghe,  1987;  Pogulis  and 
Freytag, 1993), but this sequence did not appear to affect 
the  levels or pattern  of expression of the 2,000-bp pro- 
moter in transgenic mice (Goldberg et al., 1992). We have 
examined  the  DNA  segments  upstream  of  the  mouse 
proa2(I)  collagen gene in order to find sequences that en- 
hance expression of the proximal promoter in transgenic 
mice. We report here the identification of a far-upstream 
enhancer that substantially increases the activity of the re- 
porter gene, confers a  high  degree of position indepen- 
dence on the  transgene,  and  can drive  a  220-bp  mouse 
proal(I) promoter in a cell-specific manner. 
Materials and Methods 
Isolation of Nuclei and DNase I Digestion 
Nuclei  were isolated by a modification of the procedure of Bellard et al. 
(1989). For all the solutions, 1 mM D'VF and protease inhibitors (phenyl- 
methylsulfonyl fluoride at 1 mM and pepstatin, leupeptin, and aprotinin at 
10 ixg/ml) were used. Four large plates (25 × 25 cm) of each cell line, NIH/ 
3T3  (American  Type  Culture  Collection,  Rockville,  MD),  MC3T3-E1 
(Dr. Farach-Carson, The University of Texas Dental School), EL4 (Dr. 
Platsoukas, The  University of Texas M.  D.  Anderson Cancer  Center, 
Houston, TX), and  NMuLi  (American Type Culture  Collection), were 
washed twice with ice-cold PBS. The cells were scraped in 3 ml of PBS and 
centrifuged at 1,500 rpm for 10 min in a tabletop centrifuge (model GLC- 
2B:  DuPont/Sorvall Instruments, Wilmington, DE). Mouse tissues were 
dissected  from newborn B6D2F1  mice and washed in ice-cold  PBS. Brain 
and liver tissues were then minced with scissors and treated as described 
below. Skin from newborn mice was cut into small strips and floated on a 
solution of Dispase (Collaborative Research, Inc., Waltham, MA) at 37°C 
for 30  min. The epidermis was then stripped from the  dermis and dis- 
carded. The dermis was chopped into small pieces with a razor blade and 
digested for 1 h at 37°C in a solution of 3 mg/ml collagenase (Sigma Immu- 
nochemicals, St. Louis, MO) in DME. The digested dermis was filtered 
through cheesecloth. The filtrate was centrifuged at 1,500 rpm for 10 min 
in a Sorvall  GLC-2B tabletop centrifuge. The cell pellet was either used 
immediately to prepare nuclei  or plated out in DME with 10%  fetal calf 
serum at 37°C in 8% CO2 for 36 h and harvested as described above for 
cultured cells. 
The cell  pellet  or fragments of tissue were resuspended in  10  ml of 
buffer 1 (15  mM Tris HCI, pH 7.5; 15  mM NaCI;  60  mM KCI;  1 mM 
EDTA, pH 8.0; 0.5 mM EGTA, pH 8.0; 1.9 M sucrose: 0.1% Triton X-100; 
0.5 mM spermidine; and 0.15 mM spermine) and transferred to a Dounce 
homogenizer for lysis (Kontes Glass Co., Vineland, N  J). For tissues,  the 
lysate was filtered through cheesecloth to remove any fibrous elements. 10 ml 
of buffer 2 (buffer 1 without Triton X-100)  was added to the lysed  cells 
followed by enough buffer 3 (buffer 1 without Triton X-100 or sucrose) to 
bring the refractive index of the solution to 1.40-1.42. The suspension was 
centrifuged at 4°C in an SS34 rotor at 10,000 rpm for 10 min, and the pellet 
was resuspended in 5 ml of buffer 4 (buffer 1 containing 0.34 M sucrose 
without EDTA, EGTA, or Triton X-100). The absorbance of 5 ~1 of re- 
suspended nuclei  was measured at 260 nm. The nuclei were then pelleted 
again by centrifugation for 10 min at 10,000 rpm in an SS34 rotor, and the 
pellet was resuspended in buffer 4 at an absorbance of ~0.2 OD unit/~l. 
For each digestion,  15 OD units of nuclei were used. The volume of the 
nuclei  was brought to 80 Ixl by the addition of buffer 4. 10 p.1 of DNase I 
assay buffer (400 mM Tris HCI, pH 7.5; 60 mM MgCIe) and 10 ixl of di- 
luted  DNase  I  (Pharmacia  LKB  Biotechnology,  Inc.,  Piscataway,  NJ) 
(concentrations 0-45 U/p.l) were added. The nuclei were incubated at 37°C 
for 15 min. The reaction was stopped by the addition  of 200 I~1 of stop 
buffer (50 mM Tris HC1, pH 8.0; 100 mM EDTA, pH 8.0; 100 mM NaCI; 
and 1% SDS) and 40 ILl of Proteinase K (20 mg/ml). The nuclei were then 
incubated overnight at 55°C to digest proteins. The DNA was extracted by 
phenol/chloroform, precipitated with ethanol, and resuspended in 100 p~l 
of Tris EDTA, pH 8.0. Aliquots from the DNase I-digested nuclei of each 
cell  line  were digested with the indicated  restriction endonucleases, fol- 
lowed by electrophoresis through a 1% agarose gel. The DNA fragments 
were transferred to Zeta-probe GTG membrane (BioRad Labs, Hercules, 
CA), and the blot was hybridized according to the manufacturer's recom- 
mendation. 
DNA Constructs 
The 5' flanking sequences of the mouse proa2(I) collagen  gene were de- 
rived from two sources: a cosmid clone (Cosmid 1) or a h FIX II genomic 
clone (h3-3).  The cosmid library contained genomic DNA from B6D2F1 
mice partially digested with BamHI and cloned into the BamHI site of the 
vector pWE15 (Stratagene, La Jolla,  CA). Cosmid 1 contained sequences 
of the proa2(1)  collagen  gene  from the  BamHI site  at  -17  kb  to  the 
BamHI site at  +2.5 kb. The ?` FIX II library (Stratagene) contained ge- 
nomic DNA from 129 mice partially digested with Sau3AI and cloned into 
the  Xhol  site  of the  vector.  The  clone  ?,3-3 contained  5'  flanking  se- 
quences of the proa2(1) collagen gene from about -23.5 to - 11 kb. Fig. 1 A 
contains a partial restriction map of these two clones, and Fig. 2 shows di- 
agrams of the constructs derived from these sequences. 
The following two reporter gene vectors were modified for use in gen- 
erating transgenic mice: pLacF (Mercer et al.,  1991) and pA3Luc (Wood 
et al., 1989). The lacZ vector was modified by the addition of short linkers 
containing unique restriction enzymes in the polylinker regions to gener- 
ate pLacH and pLacRM; the luciferase vector was similarly  modified to 
generate pLuc32 and pLucG. Various fragments of the mouse proa2(1) 
collagen upstream sequences were cloned into the polylinker regions of 
these four modified vectors as described below. 
A 4-kb fragment from SphI (+54) to HpaI (-3.8 kh) was blunt ended 
with T4 polymerase and cloned into the SmaI site  of pLacH (lacZ)  and 
pLuc32  (luciferase) to generate pGB41ac  and pGB41uc,  respectively.  A 
6.5-kb fragment from Sphl (+54) to BamHI (-6.5 kb) was cloned blunt 
end using a similar strategy to generate pGB6.51ac and pGB6.51uc. For the 
17-kb constructs, PCR  was used to convert the SphI site  at  +54 into a 
unique XhoI restriction site. The sequences between the Xmal site (- 108 
bp) and the XhoI site (+54 bp) were subcloned in pBluescript KS (Strat- 
agene) between XhoI and XmaI to yield  pBS54. The sequences between 
-17 kb (NotI) and  -108 bp (XmaI) were isolated from Cosmid  1 and 
cloned into pBS54 between Notl and XmaI to yield  pBS17 from -17 kb 
(NotI) to  +54  bp  (Xhol).  This fragment was excised  and  cloned  into 
pLacRM  and  pLucG  between  XhoI  and  Notl  to  yield  pGBl71ac  and 
pGB 171uc, respectively. 
For the remaining constructs, only lacZ vectors were used. Various frag- 
ments of the 5' flanking sequences were cloned upstream of a proximal 
proof2(1) collagen promoter. The proximal promoter (-350 to  +54 bp) 
was inserted blunt end into the XbaI site  of pLaeRM to yield  plac350. 
Four different fragments isolated from subclones of Cosmid 1 were in- 
serted upstream of this 350-bp  promoter by blunt-end ligation  into the 
XhoI site  to yield  pGB11.5/6.5,  pGB17/ll.5,  pGBI3.5/ll.5, and pGBI7/ 
13.5. The insert from ?`3-3 was isolated and cloned in both orientations 
into the NotI site of plac350 to generate pGB23.5/11  and pGB23.5/I l-rev. 
Two additional  constructs were made by subcloning into a  modified 
form of pBluescript containing a Bglfl site. The 6-kb Bglll fragment of h3-3 
(-13.5  to -19.5 kb) was cloned into this modified pBlucscript between 
BglII and BamHI. The insert was removed by Xhol and Notl and cloned 
into plac350  to yield  pGB19.5/13.5  or removed by BglII and  Notl  and 
cloned into m.p.lacZ (Rossert et al., 1996) to yield pGBal(l)19.5/13.5. 
Generation of Transgenic Mice 
The transgenic mice were generated using mouse prot~2(1) collagen  gene 
constructs  as  shown  in  Fig.  2.  For  constructs  in  the  pLacH  vector 
(pGB41ac and pGB6.51ac), vector sequences were removed with XhoI and 
SphI. For constructs in the pLuc32 vector (pGB41uc and pGB6.51uc), vec- 
tor sequences were removed with AatlI and XhoI. For constructs in the 
pLacRM and pLucG vectors (pGBl71ac, pGB171uc, pGB11.5/6.5,  pGBI7/ 
11.5,  pGB13.5/ll.5,  pGB17/13.5,  pGB23.5/ll,  pGB23.5/ll-rev,  and 
pGB19.5/13.5),  vector sequences were removed with Sacll and NruI. For 
the  pGBal(1)19.5/13.5  construct, vector sequences were removed with 
The Journal of Cell Biology, Volume 134, 1996  1334 XhoI and NarI. The digested DNA constructs were gel  purified, resus- 
pended at a concentration of 2 ng/pd and microinjected into the pronuclei 
of B6D2F2  fertilized  eggs as described previously (Hogan et al.,  1986). 
The injected eggs were then transferred into CD1 foster mothers. The in- 
tegration of the transgenes in founder mice was assessed by Southern blot 
analysis of DNA derived from either the tails of 1-mo-old  animals or the 
placentas of embryos. 
Assays for the Expression of Reporter Genes 
13-Galactosidase  activity  was assayed on whole embryos as previously de- 
scribed (Mercer et al,, 1991). For embryos older than E15.5, the skin was 
removed before fixation and staining.  Embryos were fixed for 45 min and 
then stained overnight at room temperature. For histological  analysis, 8-~m 
sections were cut  and  counterstained  with  eosin.  Some newborn pups 
were partially clarified  in potassium hydroxide (McLeod, 1980). 
Luciferase activity  was assayed in tissues of 4-wk-old  mice containing 
the transgene as previously described (Niederreither et al., 1992). The re- 
suits are expressed as luciferase light units per Ixg of protein. 
Results 
DNase I-Hypersensitive Sites in the 
proa2(I) Collagen Gene 
DNase I-hypersensitive sites in chromatin are frequently 
associated with control regions that confer high levels of 
expression  or that  provide  position-independent  expres- 
sion in transgenic mice. For several tissue-specific genes, 
DNase  I-hypersensitive  sites  have  been  found  far  up- 
stream of the promoter sequences (Grosveld et al., 1993; 
Kaltschmidt et al.,  1994;  Zhong et al.,  1994). These sites 
are  thought  to  play  a  role  in  regulating  expression  of 
linked  genes  through  the  binding  of  sequence  specific 
transcription  factors.  An  earlier  study in  our laboratory 
showed  that  a  cell-specific  DNase  I-hypersensitive  site 
was  present  at  about  -100  bp  in  the  promoter  of  the 
mouse proa2(I) collagen gene (Liau et al., 1986).  A similar 
hypersensitive  site  has  also  been  detected  in  the  chick 
proc~2(I) collagen gene (Beck et al., 1991), as well as other 
sites in the body of the gene. Hypersensitive sites have also 
been detected in the mouse and human proal(I) promoter 
region and gene (Barsh et al., 1984;  Breindl et al., 1984). 
To  find  elements  that  might  enhance  expression  of the 
mouse proa2(1) gene, we searched for additional  DNase 
I-hypersensitive sites in chromatin upstream of the proxi- 
mal promoter. 
A cosmid clone (Fig. 1 A, Cosmid 1) containing 5' flank- 
ing  sequences  of the  mouse proa2(I)  collagen gene was 
isolated from a  library of mouse genomic DNA partially 
digested with BamHI. Restriction mapping of this cosmid 
clone showed that it contained sequences from -17 kb up- 
stream to  +2.5  kb downstream of the  start of transcrip- 
tion. For sequences further upstream, we isolated a h FIX 
II genomic clone (h3-3), which contained sequences from 
-23.5 to -11 kb upstream of the start of transcription. We 
used fragments from these two clones to probe Southern 
blots containing DNA from nuclei  treated with DNase I 
and subsequently digested with the appropriate restriction 
enzymes (Fig. 1 A). 
The first probe, P1  (a 1.4-kb BamHI/EcoRI fragment), 
hybridized to an 8-kb BamHI fragment (-6.5 to +1.5 kb) 
(Fig. 1, A  and B). In DNA derived from DNase I-treated 
NIH/3T3 fibroblast nuclei, two additional species, 6.4 and 
4.4  kb, could be detected;  these species corresponded to 
hypersensitive sites at approximately -100 bp and -2.1 kb, 
respectively (Fig. 1 B). These hypersensitive sites were not 
detectable in DNA derived from DNase I-treated nuclei 
of EL4 cells, a T  cell line which does not produce type I 
collagen. The site located at -100 bp, designated HS1, has 
been previously described  (Liau et al.,  1986).  The other 
site (HS2), located at -2.1 kb, was significantly less hyper- 
sensitive, which could be deduced by the relative intensi- 
ties of the bands. The presence and location of both hyper- 
sensitive  sites  were  confirmed  by rehybridizing  the  blot 
with  a  probe  homologous to  the  other  end  of the  8-kb 
BamHI fragment (data not shown). 
The same blot was stripped and reprobed with fragment 
P2 (a 900-bp Asp718/BamHI fragment), which binds to a 
10.5-kb BamHI fragment (-17 to -6.5 kb) (Fig. 1 A). Two 
hypersensitive sites were seen in NIH/3T3 chromatin be- 
tween -15 and -17 kb upstream of the transcription start 
site, but not in EL4 chromatin (data not shown). No hy- 
persensitive sites were detected between -6.5 and -15 kb 
in either cell line. To further characterize the hypersensi- 
tive sites between 15 and 17 kb upstream, we isolated nu- 
clei from two additional cell lines, MC3T3-E1  (an osteo- 
blastic cell line derived from mouse calvaria) and NMuLi 
(a liver cell line). MC3T3-E1 cells express type I collagen 
(Sudo et al., 1983), whereas NMuLi cells do not (data not 
shown). After DNase I treatment of nuclei, the DNA from 
the four cell lines was digested with BglII and probed with 
P3 (1.3-kb AccI/BgllI fragment), which hybridized to a 6-kb 
BgllI fragment (-19.5 to -13.5 kb) (Fig. 1 A). Three hy- 
persensitive bands could be seen in DNA from NIH/3T3 
and MC3T3-E1 cells but not in DNA from ELA or NMuLi 
cells (Fig. 1 C). These sites were mapped to approximately 
-15.5, -16.2, and -17.1 kb and designated HS3, HS4, and 
HS5, respectively. The presence and location of these hy- 
persensitive bands was confirmed by rehybridizing with a 
probe homologous to the other end of the 6-kb BgllI frag- 
ment (data not shown). The same blot was stripped and re- 
hybridized  to fragment P4  (a 600-bp  BamHI/BglII frag- 
ment), which binds to an 8.5-kb BglII fragment from -28 
to -19.5 kb. No major hypersensitive sites were seen with 
this probe (data not shown). 
We also isolated nuclei from tissues of newborn mice to 
determine whether the hypersensitive sites that were de- 
tected with cultured  cells were also present in mouse tis- 
sues. We used newborn mouse skin, which expresses high 
levels of type I  collagen  as  a  positive tissue,  and  mouse 
brain, which expresses very little type I collagen as a nega- 
tive  tissue.  Nuclei  derived  from  brain  and  skin  were 
treated  with  DNAse  I  and  subsequently  digested  with 
BamHI and probed with P1 to show the presence of HS1 
and HS2. These hypersensitive sites were only evident in 
DNA derived from skin fibroblasts (data not shown). We 
then digested the DNAse I-treated DNAs with BglII and 
probed with P3 to show HS3-5. Fig. 1 D  shows that these 
hypersensitive sites were detected in chromatin from skin 
fibroblasts but not in chromatin from brain cells. The loca- 
tion  of the  hypersensitive sites in  chromatin of cultured 
cells  and mouse tissues  was identical.  Moreover, we did 
not detect any new hypersensitive sites confirming the re- 
sults obtained with cultured cell lines. 
Five  major  hypersensitive  sites  were  shown  to  be 
present in discrete locations in the region between -28 kb 
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sitive  sites  in  chromatin  of 
the 5' flanking region of the 
mouse  proa2(I)  collagen 
gene.  (A)  A  partial restric- 
tion  map  of  the  mouse 
proa2(1) collagen gene from 
-28 to  +1.5 kb with respect 
to the start site of transcrip- 
tion. The locations of the five 
hypersensitive  sites  (HS1- 
HSS) are  shown  as  well  as 
the  probes (P1-P4) used  in 
hybridization.  Diagrams  of 
the two genomic clones used 
in this study, Cosmid  1 and 
k3-3, are also shown. In B-D, 
nuclei  of  the  indicated  cell 
lines  and  tissues  were  di- 
gested  with  increasing  con- 
centrations of DNase  I.  (B) 
DNA from fibroblasts (NIH/ 
3T3) and T  cells (EL4) was 
digested with BamHI and hy- 
bridized with probe P1.  The 
arrows  indicate the  position 
of the  species derived from 
DNase I-digested DNA (6.4 
and 4.4  kb). (C)  DNA from 
fibroblasts (NIH/3T3), osteo- 
blasts  (MC3T3-E1), T  cells 
(EL4), and liver cells (NMuLi) 
was digested with BglII and 
hybridized  with  probe  P3. 
The arrows indicate the posi- 
tion  of  the  species  derived 
from DNase I-digested DNA 
(3.6,  2.7,  and  2.0  kb).  (D) 
DNA  from  brain  cells  and 
skin fibroblasts was digested 
with  BglII  and  hybridized 
with  probe  P3.  The  arrows 
indicate  the  position  of  the 
species derived from DNase 
I-digested  DNA  (3.6,  2.7, 
and 2.0 kb). 
and  +1.5  kb of the mouse proa.2(I)  collagen gene. These 
sites were present in type I  collagen-producing cells, but 
they were not found in cell types that do not produce type I 
collagen. The  existence of these  hypersensitive sites sug- 
gested that the DNA in chromatin at or around these sites 
was accessible to DNA-binding proteins in cells that syn- 
thesize type I  collagen but not in other cell types. To test 
the effects of the segments  containing the  hypersensitive 
sites  on  transcriptional  activity,  we  made  several  pro- 
moter-reporter gene constructs with 5' flanking sequences 
and introduced them into transgenic mice. 
Generation of Transgenic Mice 
Transgenic  mouse  lines were  generated  using  the  mouse 
proa2(1)  collagen gene constructs shown in Fig. 2  and de- 
scribed  in  detail  in  the  Materials  and  Methods  section. 
Mice harboring the pGB4, pGB6.5, and pGB17 constructs 
were  coinjected with  two  separate  DNA  constructs:  one 
containing  the  promoter  fragment  fused  to  the  lacZ  re- 
porter  gene  and  one  containing  the  promoter  fragment 
fused to the luciferase reporter gene. Animals found to be 
positive by Southern blot analysis were always positive for 
both reporter genes. For the other constructs shown in Fig. 2, 
only lacZ reporter genes were used. 
For  most  of  the  DNA  constructs  that  were  microin- 
jected, we sacrificed the foster mothers at 15.5 d  of gesta- 
tion and stained the founder animals for lacZ activity. How- 
ever,  for  the  pGB17,  pGB6.5,  pGB17/ll.5,  and  pGB17/ 
13.5  constructs,  a  small number  of pups were  allowed to 
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various  constructs  intro- 
duced  into  transgenic  mice. 
The  locations  of  the  three 
upstream hypersensitive sites 
HS3-HS5  are  indicated  by 
the  arrowheads.  (A)  Con- 
structs  in  which the  mouse 
proa2(I)  collagen  far-up- 
stream  enhancer  sequences 
are  linked  to  the  mouse 
proct2(I)  collagen  350-bp 
proximal  promoter.  (B)  A 
construct  in  which  the 
mouse proa2(I) collagen far- 
upstream  enhancer  se- 
quences  are  linked  to  the 
mouse  procd(I)  collagen 
220-bp proximal promoter. 
come to term and positive founder animals were used to 
establish transgenic lines. 
Expression of a proa2(I) Collagen lacZ Transgene in 
Whole Embryos 
After overnight staining for 13-gatactosidase,  embryos har- 
boring either the 2,000-bp construct (-2,0001acZ) or the 
350-bp construct (-3501acZ) showed relatively faint blue 
staining in various mesenchymal cells (Niederreither et al., 
1992).  LacZ staining was detectable in about 40% of the 
lines that were positive by Southern blot analysis (Table I). 
In the 12 embryos positive by Southern blot analysis for a 
construct that contained 3.8 kb upstream of the transcrip- 
tion  start  site  (pGB4), expression of the lacZ transgene 
was not detectable (Table I). This finding was surprising 
because these constructs include the 2,000-bp promoter se- 
quences,  which  direct  expression  of  [3-galactosidase  in 
transgenic mice, albeit at relatively low levels. Similarly, 
among 13 embryos positive by Southern blot analysis for a 
construction containing 6.5  kb upstream of the transcrip- 
tion start site (pGB6.5), expression of the lacZ gene was 
not detectable (Table I). These data suggested that there 
were silencing elements located in the promoter upstream 
of 2,000 bp that were capable of strongly suppressing the 
transcriptional  activity of this  promoter. The pGB4  and 
pGB6.5  constructs  contained  DNA  segments  in  which 
HS1 and HS2 were identified, whereas the previously in- 
jected  350-  and  2000-bp  promoter  constructs  contained 
DNA segments in which only HS1 was identified (Fig. 1). 
It is possible that the sequences around HS2 mediate the 
silencing effects seen in pGB4 and pGB6.5. 
In contrast to the complete absence of X-gal staining in 
embryos transgenic for the 3.8-  and 6.5-kb promoter se- 
quences,  six  of the  eight  embryos harboring  sequences 
from -17 kb to +54 bp (pGB17), which were found to be 
positive by Southern blot analysis, expressed the transgene 
(Table  I).  Moreover,  13-galactosidase  staining  was  very 
strong in these embryos. In Fig. 3, A  and B, we compare 
the intensities of X-gal staining at E15.5 in representative 
embryos of the -20001acZ and the pGB17 transgenic mice. 
Embryos  harboring  the  pGB17  construct  were  stained 
very strongly in the skin and appeared almost completely 
blue in whole-mount views, although not all cells in these 
mice were stained as revealed by histology (see below). 
The  pGB17  construct  contained  a  DNA  segment  in 
which four hypersensitive sites, HS1 to HS4, were identi- 
fied (Fig.  1).  In  this  construct, the silencing effects seen 
with sequences in pGB4 and pGB6.5 were overcome by 
Table L Percent of Mice Expressing the lacZ Transgene 
Positive  13-gal  Percent  Intensity of 
Construct  by Southern  expressors  expressors  staining* 
-3501acZ  8  3  38  + 
pGB4  12  0  0  - 
pGB6.5  13  0  0  - 
pGBI7  8  6  75  ++++ 
pGB 11.5/6.5  2  0  0  - 
pGB 13.5/11.5  4  0  0  - 
pGB 19.5/13.5  6  4  67  +  +  +  + 
pGBI7/I 1.5  10  9  90  +++++ 
pGB 17/13.5  5  4  80  +  + +  + 
pGB23.5/11  7  7  100  +  + +  + 
pGB23.5/11/1 l-rev  6  5  83  + +  +  + 
pGBet 1 (1)19.5/13.5  10  7  70  + +  + + 
* Average levels of expression after overnight staining. 
-, no detectable staining. 
+, weak staining. 
+ + + +, strong staining. 
+ + + + +, very strong staining. 
Bou-Gharios et al. A Far-Upstream Enhancer in the Mouse Colla2 Gene  1337 Figure 3.  13-Galactosidase staining in typical whole-mount embryos at E15.5 harboring -2,0001acZ  (A), pGB17 (B), and pGB17/ll.5 
(C). Note the increased intensity of X-gal staining in embryos harboring constructs containing the far-upstream enhancer.  The embryos 
shown in B and C are both transgenic founders,  whereas the embryo shown in A is from a transgenic  line. Differences  in the staining 
pattern of embryos B and C could be due to chimerism in the founder animals. (D) The intensity of staining in founder animals harbor- 
ing the pGB17/ll.5 construct after 4 h of staining. The arrow points to a negative control. Bar, 1 mm. 
sequences located further upstream. The presence of these 
upstream regions also resulted in a  considerable increase 
in  the  activity of the  lacZ  reporter  gene  over the  levels 
seen in mice harboring either 2,000 or 350 bp of the pro- 
moter, suggesting that a strong enhancer is present. 
To  further  delineate  the  sequences  necessary  for  en- 
hancing activity, we cloned various fragments of the far- 
upstream region 5'  to the  350-bp proct2(I) collagen pro- 
moter  and  generated  transgenic  mice.  In  positive  E15.5 
embryos, f3-galactosidase activity correlated with the pres- 
ence  of the  DNA  segments in  which  the  hypersensitive 
sites had been identified.  Constructs with DNA segments 
in which the three upstream hypersensitive sites (HS3 to 
HS5)  or  only  HS3  and  HS4  had  been  identified  gave 
strong lacZ expression in transgenic mice (Table I). These 
constructs  included  pGB17/ll.5,  pGB17/13.5,  pGB19.5/ 
13.5, pGB23.5/ll, and pGB23.5/ll-rev. As shown with the 
pGB23.5/ll-rev construct, the far-upstream region was ac- 
tive in the reverse orientation as well as in the normal ori- 
entation. On the other hand, embryos transgenic for con- 
structs, with DNA segments lacking HS3 to HS5, showed 
no  X-gal  staining.  Specifically,  two  embryos positive by 
Southern blot analysis for the pGB11.5/6.5  construct and 
four  embryos positive by Southern  blot  analysis for the 
pGB13.5/11.5  construct  did  not  express  lacZ  (Table  I). 
These results strengthen the notion that a silencer region 
lies upstream of -2,000 bp and could extend upstream to 
approximately -13.5 kb. The effect of this silencer region 
was overcome by the presence of DNA segments in which 
some or  all  of the  far-upstream hypersensitive  sites  had 
been identified. 
The  strongest  levels of staining  were  seen in  embryos 
harboring the pGB17/ll.5 construct (Fig. 3 C). The X-gal 
staining of some of these embryos became visible in 60 min 
and was complete by 4 h  (Fig. 3 D). Other embryos were 
only partially stained  at 4  h  but stained completely after 
overnight incubation  with X-gal.  Of 10 embryos positive 
by Southern  blot  analysis,  nine  expressed the  transgene 
(Table I). A  shorter construct, pGB17/13.5, was expressed 
in  four  of five  mice  positive  by  Southern  blot  analysis, 
whereas the pGB19.5/13.5 construct was expressed in four 
of six mice,  the  pGB23.5/ll  construct  was  expressed  in 
seven  of seven  mice,  and  the  pGB23.5/ll-rev  construct 
was expressed in five of six mice (Table I). 
Although the pGB19.5/13.5, pGB23.5/ll, and the pGB23/ 
5/ll-rev constructs all contain DNA segments in which the 
three far-upstream hypersensitive sites (HS3 to HS5) were 
identified, the level or pattern of staining in embryos har- 
boring this DNA was similar to that seen in embryos trans- 
genic  for  the  pGB17  construct  or  transgenic  for  the 
pGB17/ll.5  or  pGB17/13.5  constructs,  which  contain 
DNA segments in which only HS3 and HS4 were identi- 
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tional redundancy in these sites and that the presence of 
a segment containing the sequence in which two DNase 
I-hypersensitive sites were identified is adequate for opti- 
mal expression. 
These results indicated that an enhancing region is lo- 
cated between -13.5 and -19.5 kb of the mouse proa2(I) 
collagen  gene.  The  same  region  was  shown  to  contain 
three  cell-specific DNase  I-hypersensitive sites,  HS3  to 
HS5  (Fig.  1).  We  have  denoted  this  region  the  far-up- 
stream enhancer of the mouse protr2 (I) collagen gene. 
Luciferase Activity in Tissues of Transgenic Mice 
Luciferase activity was assayed in homogenates of tissues 
from 4-wk-old  mice  that  were  shown  by Southern  blot 
analysis to harbor the transgene. Table II shows the levels 
of luciferase in tissue extracts of three strains  harboring 
the pGB17 construct compared with two strains with the 
350-bp luciferase construct. The much higher levels of lu- 
ciferase activity seen in mice carrying the 17-kb promoter 
confirms the presence of an enhancer element in the larger 
construct. In  one of the  strains  transgenic for the  17-kb 
promoter, the levels of luciferase activity in many tissues 
were considerably higher than  in  the  two  other strains. 
These differences were perhaps due to the site of integra- 
tion of the transgene, but they did not appear to depend 
on the number of copies of the transgene integrated. 
The highest levels of expression were seen in tail, fol- 
lowed by bone (calvarium) and skin, which are tissues that 
express high levels of the endogenous gene. Since all or- 
gans, including soft tissues such as liver and brain, contain 
some  mesenchymal  cells  or  fibroblasts,  which  produce 
type I collagen, it was not surprising to see expression of 
the transgene in every tissue tested, but the values of lu- 
ciferase activities in tissues which express relatively little 
type I collagen were at least 20-100 times lower than the 
values in tail. 
The luciferase activities in tissues of mice transgenic for 
the pGB6.5 construct were much lower than the activities 
in tissues of mice harboring the pGB17 construct. These 
activities were also lower than those in mice carrying the 
350-bp proximal promoter. Indeed, the expression in sev- 
eral tissues became undetectable in mice transgenic for the 
6.5-kb construct (Table II). Overall, the results of luciferase 
assays in different tissues confirmed the lacZ staining pat- 
terns, which indicated that there was no detectable stain- 
ing in transgenic embryos carrying pGB6.5, weak staining 
in  embryos harboring  -3501acZ,  and  strong  staining  in 
embryos  transgenic  for  pGB17,  thereby  demonstrating 
that there was a potent enhancer element present in the 
pGB17 construct and a  silencer element included in  the 
pGB6.5 construct. 
Histochemical Localization of fl-Galactosidase Activity 
in E15,5 Embryos 
X-gal-positive embryos were examined at 15.5 d of embry- 
onic development because many bone primordia begin to 
ossify at this stage, but the skin has not yet fully devel- 
oped, allowing penetration of the X-gal substrate in intact 
embryos. In all embryos transgenic for the constructs con- 
Table II. Luciferase Levels in Tissues of 4-wk-otd Transgenic 
Mice * 
6.5-kb 
350-bp lines  lines  17-kb lines 
Luciferase copy 
number  1  1  1  3  3  5  1 
Tissue 
Tail  140  220  80  3.2  1,900,000  71,000  34,000 
Skin  260  350  12  0.54  47,000  5,500  6,300 
Calvarium  0.14  0.88  0  0.57  42,000  8,500  6,900 
Liver  0  0  0  0  610  45  44 
Heart  1.1  1.1  0  0  1,900  400  250 
Lung  0  0  0  0  7,900  2,500  1,300 
Brain  0.28  65  0  0.1  720  200  250 
Kidney  0  6.6  0  0  3,300  420  300 
Thymus  0  0.44  5  2.9  3,900  120  63 
Intestine  0  0.88  0  0  3,500  1,200  480 
*Luciferase values are expressed as Light Units per p,g protein. 
taining  the  far-upstream  enhancer  sequences,  the  lacZ 
gene was expressed in a very similar pattern (Table III). 
E15.5 transgenic embryos showed expression of lacZ in 
many but not all cell types in which the endogenous gene 
is active. In all embryos examined, fibroblast-specific X-gal 
staining was detected in the connective tissue layers of the 
dermis and fascia. Fig. 4 A  shows a parasagittal section of 
an embryo in which very intense staining was evident in 
the connective tissue layers between the epidermis and the 
muscle. Expression also occurred in fibroblasts between 
the muscle bundles, whereas the liver cells and the chon- 
drocytes of the ribs were completely negative, as were the 
epidermal cells. Expression in fibroblasts throughout the 
gastrointestinal  tract  was  also  seen.  X-gal  staining  was 
present in the fibrous elements of the submucosa and mus- 
cularis layers of the stomach but not in the epithelial mu- 
cosal cells (Fig. 4 B). Fibroblasts in many tendons were 
also  stained  with  X-gal  (Fig.  4  C).  Fibroblasts  in  the 
meninges (Fig. 4 D) surrounding the spinal cord and the 
brain were positive for X-gal. The kidney capsule and con- 
Table IlL Expression Pattern of the LacZ Transgene 
E15.5  Newborn 
pGB  pGB  pGB  pGBa I  pGB 
pGB17  17/11.5  17/13.5  19.5/13.5  19.5/13.5  pGBI7  17/13.5 
OSTEOBLASTS 
Frontal/Parietal  +  +  +  +  +  +  + 
Clavicle  +  +  +  +  +  +  + 
Mandible  +  +  +  +  +  +  + 
Other bones  ....... 
Odontoblasts  ND  ND  ND  ND  ND 
FIBROBLASTS 
Dennis/Fascia  +  +  +  +  +  +  + 
Tendon  ±  _  ±  _+  +_  ±  ___ 
Meninges  +  +  +  +  +  +  + 
GI Tract  +  +  +  +  +  +  + 
Kidney  +  +  +  +  +  +  + 
Testis  +  +  +  +  +  +  + 
Blood vessels  .....  +  + 
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staining (Fig. 4 E), whereas the cells in the glomeruli were 
not. In the testis,  the stromal fibroblasts were X-gal posi- 
tive but not the primitive Sertoli cells and spermatogonia 
in the testical cords that mature into the seminiferous tu- 
bules (Fig. 4 F). 
Bone ossification starts at E13.5 to E14.5 in the clavicle, 
followed at  later  times  by other bones  (Rugh,  1990).  At 
E15.5, X-gal staining of embryos was seen in some ossifi- 
cation centers (Table III), i.e., in osteoblasts of the frontal 
and parietal bones of the skull, in the clavicle (Fig. 4  G), 
and in the maxillary and mandibular bones, but very little 
in  other  bones.  Occasional  blue-stained  cells,  which  ap- 
peared to be osteoblasts by their morphology, were associ- 
ated  with  regions  of  subperiosteal  ossification  of  long 
bones  in  some  embryos;  however,  there  was  no  X-gal 
staining detected in regions of endochondral ossification. 
In human embryos, the frontal and parietal  bones of the 
skull are formed entirely by intramembranous ossification, 
whereas  the  maxilla,  mandible,  and  clavicle  are  formed 
partially by intramembranous ossification and partially by 
endochondral  ossification  (Gardner,  1971).  Hence,  the 
pattern  of X-gal staining  in forming bones  of E15.5  em- 
bryos appeared  to largely correlate  with the  presence  of 
osteoblasts in ossification centers  that were generated by 
intramembranous ossification. 
In conclusion, X-gal staining of embryos transgenic for 
constructs containing the far-upstream enhancer was much 
stronger  than  in  embryos harboring  either  a  2,000-  or  a 
350-bp promoter. Although the intensity of staining varied 
somewhat from embryo to embryo, staining  was specific 
for cells of mesenchymal origin, including fibroblasts  and 
some osteoblasts. No staining was detected in various cell 
types that did not express the endogenous type I collagen 
gene, such as epithelial cells, neuronal cells, or the paren- 
chymal cells of the spleen, liver, etc. Clearly, however, not 
all  type  I  collagen-producing  cells  expressed  the  trans- 
gene. Possible reasons for the lack of transgene expression 
in many osteoblasts are discussed in more detail later. 
Histochemical Localization of ~-Galactosidase Activity 
in Newborn Pups 
Three newborn pups harboring the pGB17 construct and 
two  newborn  pups  harboring  the  pGB17/13.5  construct 
were  examined.  We  observed  significant  X-gal  staining 
surrounding blood vessels  in newborn mice that was not 
seen  in  embryos  at  E15.5.  Fig.  4  H  shows  the  staining 
around some of the blood vessel walls of newborn pups. 
After  removal  of  the  skin  and  clarification  (McLeod, 
1980), it was possible  to see  the  overall pattern  of X-gal 
staining in bones of the pups. Fig. 4 J  shows the heads of 
two  different  newborn  pups,  one  harboring  the  pGB17/ 
13.5 construct and one harboring the 3.2-kb proal(I) col- 
lagen promoter (3,2001acZ).  It was previously shown that 
pups containing either 2.3 or 3.2 kb of the mouse procd(I) 
collagen promoter strongly expressed  a  lacZ  transgene 
in  osteoblasts  of all  bones,  including  those  of the  skull 
(Rossert et al., 1995). As expected, the pup harboring the 
3.2-kb proetl(I) collagen promoter showed very strong ex- 
pression in the various skull bones; however, the pup har- 
boring pGB17/13.5 revealed a much more limited and less 
intense  pattern  of staining  (Fig. 4 J).  Strong staining was 
seen mainly in the sutures where there are many fibroblas- 
tic cells and recently differentiated  osteoblasts. Histologi- 
cal sectioning confirmed that cells that appeared to be os- 
teoblasts  by  their  morphology  were  staining  as  well  as 
fibroblasts in the connective tissue (data not shown). Simi- 
lar  patterns  of expression  of the  transgene  in  the  skull 
were seen with  the  other newborn  pups examined  (data 
not  shown).  These  data  suggested  that  the  majority of 
transgene expression in the bones of these pups was con- 
fined to areas of new bone growth where osteoblasts were 
in the  process of differentiating  from their mesenchymal 
precursors. As with E15.5 embryos, occasional expression 
was also detected weakly in the periosteal  region of long 
bones, including the ribs (data not shown). 
To determine  whether odontoblasts were positive, sec- 
tions through  the jaw were  made  from several  newborn 
Figure 4.  Micrographs of histological sections showing the localization of 13-galactosidase staining.  All embryos harboring constructs 
containing the far-upstream enhancer showed similar  patterns of expression.  The follogving micrographs were chosen to illustrate the 
general patterns seen. (A-G) Sagittal  sections of embryos at E15.5. (A) An embryo harboring pGB17/ll.5 with staining in connective 
tissue cells of the dermis, the fascia, and the fibroblasts (arrows) of the skeletal muscle (m). Note the lack of staining in the cells of the 
epidermis (arrowheads), the liver  (L), and the chondrocytes (c) of the ribs. (B-F) Sections from embryos harboring the pGB17 con- 
struct.  (B) Staining is seen in the smooth muscle and fibroblastic cells in the muscularis externa (arrowheads) and in the submucosal 
(open arrow) layers of the stomach wall, whereas the epithelial cells (e) of the rugal folds are not stained. (C) Staining in the tendon (ar- 
row) of the elbow merging into the surrounding skeletal muscle (m). The chondrocytes (c) of the developing humerus are negative. (D) 
The meninges (arrow) surrounding the spinal cord (sp) were stained, while the neural tissues and the chondrocytes of the ribs (c) were 
negative. (E) Staining in the fibroblastic cells of the kidney capsule (small arrow) and connective tissue (large arrow). There is also some 
staining associated with tubular cells (open arrow) but not with the glomeruli (g). (F) The testis in which the cytoplasm of the interstitial 
cells (arrows) were stained, but the primitive spermatogonia and Sertoli cells (arrowheads) were not. (G) The clavicle of an embryo har- 
boring the pGB19.5/13.5  construct with blue-stained osteoblastic cells (arrows) associated with the osteoid. (H) Histological section ol a 
newborn pup harboring pGB17/13.5 showed staining in several of the small arteries of the body wall (arrows), while the chondrocytes of 
a rib and surrounding muscle were negative. (/) Expression in the fibrous submucosal (open arrow) and muscular layers (arrow) of the 
intestine of an E15.5  pup harboring the pGBed(I)19.5/13.5 construct. No staining is seen in the epithelial  cells (e). (J) Whole-mount 
staining of newborn pups from two transgenic lines after removal of the skin showed the overall expression pattern in the bones of the 
skull. Note that the 3.2-kb protxl(I) promoter (left) was expressed strongly throughout the skull bones, whereas the pGB17/13.5  con- 
struct (right) was most strongly expressed in the sutures. The bones of the skull are indicated as nasal (n), frontal (f), parietal (p), inter- 
parietal (i), and supraoccipital (s). (K) In the frontal bone of the skull of an E15.5 pup harboring the pGBal(I)19.5/13.5 construct, os- 
teoblasts are strongly stained (small arrows) and the overlying fibroblasts are stained less intensely (large arrow). There is also staining 
in meningeal fibroblasts  (open arrow) between lobes of the brain but not in the brain itself (b). (A-I, K) Bars, 100 microns. (J) Bar, 1 mm. 
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not stain with X-gal, whereas osteoblasts in the surround- 
ing  mandibular  bone  were  positive  (data  not  shown). 
Again, this contrasts with the pattern seen with newborn 
pups harboring 2.3  or 3.2  kb of the mouse proal(I) col- 
lagen  promoter  in  which  the  odontoblasts  are  strongly 
stained (Rossert et al., 1995). Table III summarizes the tis- 
sues  in  which  mesenchymal  and  fibroblastic  cells  were 
X-gal positive in newborn pups and embryos at E15.5. 
Activity of the Enhancer Cloned Upstream of the 
Mouse proal(I) Collagen Minimal Promoter 
The short mouse prot~l(I) collagen promoter from -220 
to +110 bp linked to a lacZ transgene has been shown to 
be essentially silent in transgenic mice (Rossert et al., 1996). 
We asked whether the far-upstream enhancer segment of 
the proa2(I) collagen gene from -19.5 to -13.5 kb could 
activate this promoter. The rationale was that any expres- 
sion detected would likely be dependent on the presence 
of the proct2(I) collagen enhancer region. 
As with constructs linked to the protx2(I) collagen prox- 
imal promoter, staining in whole-mount embryos was very 
strong (data not shown).  Histological analysis of several 
pups  containing  the  chimeric  construct  (pGBal(I)19.5/ 
13.5) showed that staining in these embryos was specific to 
type I  collagen-producing cells with a  pattern of expres- 
sion identical to that seen in mice transgenic for the pGB17 
construct. Fig. 4 I shows expression of the pGBal(I)19.5/ 
13.5 construct in intestine at E15.5. Fig. 4 K shows expres- 
sion in the osteoblasts of the calvaria as well as fibroblasts 
of the  fascia and the  meninges  of the  brain.  These data 
suggest  that  the  far-upstream  enhancer  of  the  mouse 
proa2(I) collagen gene is capable of conferring tissue-spe- 
cific expression to a linked promoter. 
Discussion 
We have identified an enhancer in the mouseproa2(I) col- 
lagen gene located in the region between 13.5  to 19.5  kb 
upstream of the start site of transcription, which greatly in- 
creases expression  of reporter genes in  transgenic mice. 
This enhancer exerts its effects at various distances from 
the promoter and in either orientation. Moreover, the en- 
hancer directs high levels of cell-specific expression of the 
prowl(I)  collagen  minimal  promoter,  which  has  been 
shown to be virtually silent in transgenic mice. In chroma- 
tin,  this  element  was  characterized  by  the  presence  of 
three cell-specific DNase I-hypersensitive sites located 15 
to  17  kb upstream of the  start site of transcription.  The 
level of expression of luciferase and lacZ reporter genes in 
mice with constructs containing the far-upstream enhancer 
was significantly higher than the levels seen in constructs 
lacking the enhancer. 
We believe that this sequence is important in controlling 
expression of the endogenous gene since the hypersensi- 
tive sites were found only in cells that produce type I col- 
lagen,  suggesting that  these  sites play a  role in the tran- 
scription  of  a  gene  expressed  only  by  these  cell  types. 
DNAse I digestion of chromatin derived from skin fibro- 
blasts and cell lines producing type I collagen showed the 
presence of five major hypersensitive sites in  the  region 
between the BamHI site at  +l.5kb and the BgllI site at 
-28 kb. None of these hypersensitive sites was detected in 
the chromatin of brain cells or in cell lines that did not pro- 
duce  type  I  collagen.  We  designated  these  sites  HS1  to 
HS5, beginning with the site previously described at -100 
bp. All mice transgenic for constructions containing DNA 
segments  in  which  all  three  far-upstream  hypersensitive 
sites (HS3 to HS5) were identified or segments in which 
only HS3 and HS4 were identified expressed high levels of 
the reporter genes.  In contrast,  embryos containing con- 
structions lacking these sequences showed low or no mea- 
surable activity. Hence, a direct correlation exists between 
DNA segments with enhancer activity and those in which 
the far-upstream DNase I-hypersensitive sites were iden- 
tified. Moreover, the enhancer region was able to activate 
transcription of a reporter gene in transgenic mice when it 
was placed in its natural position at 15 to 17 kb upstream 
of the start site of transcription with silencer sequences lo- 
cated between the enhancer and the promoter. 
Regions of DNase I-hypersensitivity sites are frequently 
associated  with  transcriptional  control  of  tissue-specific 
genes as in the human 13 globin gene cluster, which is con- 
trolled by a strong cell-specific enhancer known as the lo- 
cus control region (LCR) 1 containing four hypersensitive 
sites approximately 15 kb upstream (Grosveld et al., 1993). 
Like the proximal promoters of the ~ and 13 globin genes, 
which can direct erythroid-specific expression of a  trans- 
gene at low levels in the absence of the LCR (Townes et al., 
1985;  Chada  et  al.,  1986),  a  short  proximal  promoter 
(-350 to +54 bp) of the mouseprooa?(I) collagen gene can 
drive low levels of fibroblast-specific expression of a  re- 
porter  gene  in  transgenic  mice  (Goldberg  et  al.,  1992; 
Niederreither et al., 1992).  In this study, we show that the 
addition of an upstream sequence (-19.5 to -13.5 kb) to a 
minimal  mouse  proa2(I)  collagen  promoter  greatly  en- 
hanced reporter gene expression. Furthermore, when con- 
structs  lacking  the  far-upstream  enhancer  were  used  to 
generate  transgenic  mice, they occasionally showed  pro- 
miscuous expression in tissues that do not express the en- 
dogenous gene, such as in the brain (Goldberg et al., 1992; 
Niederreither et al., 1992).  However, there was no promis- 
cuous  expression  in  embryos  harboring  constructs  that 
contain  the  far-upstream enhancer  fragment.  Moreover, 
the ratio of mice that expressed the transgene over mice 
that  were  positive  by  Southern  hybridization  also  in- 
creased  in  mice  harboring  constructions  containing  the 
far-upstream  enhancer,  suggesting  that  the  constructs 
were less likely to be suppressed by the effects of flanking 
sequences. However, unlike the situation with the 13-globin 
LCR,  there  was  no  correlation  between  the  number  of 
copies of the transgene and its level of expression (Table II). 
Histological  analysis  of  15.5-d  embryos  and  newborn 
mouse  pups  containing  constructions  with  the  far-up- 
stream  enhancer  fragment  showed  that  only  mesenchy- 
maUy derived cells, such as fibroblasts of the skin, fascia, and 
tendon and osteoblasts of the calvaria, clavicle, and man- 
dible,  express the  transgene.  In this  study we show that 
mesenchymal cells in tissues such as the abdominal viscera 
were also stained for X-gal in mice harboring the far-up- 
1. Abbreviation used in this paper: LCR, locus control region. 
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the promoter, staining in these cells was  not detectable, 
perhaps due to the much lower level of promoter activity. 
In newborn animals,  transgene expression could also be 
detected in smooth muscle cells in the walls of blood ves- 
sels; no staining in blood vessels was detected at E15.5. It 
has been shown in sheep that  type I  collagen levels in- 
crease  in  the  aorta  in  the  immediate  perinatal  period 
(Bendeck and LangiUe, 1991). A  similar phenomenon in 
mice  might  explain  the  observation  of significant  X-gal 
staining in blood vessel walls only in newborn pups. Bed- 
alov et al.  (1994) have recently shown by RNA  analysis 
that the proal(I) collagen gene is highly expressed in the 
aorta of 7-d-old mice. The same group showed that a hu- 
man  minigene  construct  that  contains  2.3  kb  of  the 
procd(I) collagen promoter linked to the first five and last 
six intron/exon units and 2 kb of 3' flanking sequences was 
expressed in the aorta of transgenic mice by Western blot 
analysis of tissue extracts, whereas a construct containing 
3.5 kb of the rat proetl(I) collagen promoter fused to the 
CAT gene had no activity in smooth muscle cells (Bedalov 
et  al.,  1994).  These  data  suggest  that  elements  in  the 
proal (I) collagen gene that control expression in vascular 
smooth muscle cells might be present in the gene itself or 
in the 3' flanking sequences, whereas similar elements for 
the proa2(I) collagen gene appear to be located in a far- 
upstream enhancer. 
Only a  subset  of osteoblastic cells expressed the lacZ 
transgene. In E15.5 embryos and newborn pups, histologi- 
cal analysis indicated that some osteoblasts in calvarium, 
mandible, and clavicle were stained with X-gal. In human 
embryos, these bones are known to be formed either com- 
pletely or in part by intramembranous ossification (Gard- 
ner, 1971).  In contrast, osteoblasts in other bones, includ- 
ing  the  long  bones  of  the  limbs,  were  largely  X-gal 
negative. Occasional expression of the transgene was seen 
in long bones in regions of periosteal ossification, but no 
expression was seen in areas of endochondral ossification. 
The most strongly stained regions of the bones in newborn 
animals correlated with regions of new bone growth. This 
is evident in newborn calvaria where only the areas close 
to the sutures stained strongly with X-gal. Cells in more 
mature areas of bone had low or no staining, suggesting 
that osteoblasts were losing transgene expression as they 
matured. This pattern of osteoblast staining was in sharp 
contrast with that observed in mice harboring specific seg- 
ments of the mouse proal(l)  collagen promoter (Rossert 
et al., 1995) or a  human proed(I) construct (Liska et al., 
1994)  which  were  strongly  expressed  in  all  osteoblasts. 
Similarly, odontoblasts were X-gal negative in mice carry- 
ing the far-upstream proc~2(I)  collagen enhancer, whereas 
the same cells were strongly positive in newborn mice with 
the proal(I) collagen gene promoter (Rossert et al., 1995). 
Several different explanations are possible for the pat- 
tern of osteoblast expression in transgenic mice carrying 
the far-upstream proa2(I) collagen enhancer. One possi- 
bility is  that the osteoblasts that form intramembranous 
bones and those that form endochondral bones respond to 
different genetic programs of development. Evidence con- 
sistent with the  existence of a  separate genetic program 
comes from the observation that a human genetic disease, 
cleidocranial dysplasia, shows malformation of membra- 
nous bones such as the calvaria and clavicle, whereas long 
bones are  largely unaffected (McKusick,  1988).  If there 
were a separate genetic program for membranous and en- 
dochondral osteoblasts, it would exist in addition to a pro- 
gram that would direct expression of type I collagen genes 
in  all  osteoblasts,  as  evidenced  by  the  activity  of  the 
proal(I) collagen promoter in all osteoblasts of transgenic 
mice (Rossert et al., 1996). 
A  different hypothesis to account for the X-gal staining 
in  early  osteoblasts  from  membranous  bones  is  that  it 
could be due to transgene expression by the mesenchymal 
precursors of these cells (the half-life of the ~-galactosi- 
dase enzyme in various cells of the embryo is unknown). 
In favor of this view, we have observed X-gal staining in 
some early chondrocytic cells that have just differentiated 
from mesenchymal precursors, but this staining is rapidly 
lost as the cells mature  (data not shown).  However, we 
found that the X-gal staining in osteoblasts from membra- 
nous bones is often stronger than that seen in surrounding 
fibroblasts, suggesting that new [3-galactosidase enzyme is 
being synthesized in these cells. It is possible that osteo- 
blasts or preosteoblasts at the edges of membranous bones 
are subjected to a boost in the expression of the type I col- 
lagen genes, which is reflected in strong X-gal staining in 
these cells in transgenic mice. 
Although  transgenic mice containing the far-upstream 
enhancer  expressed  the  reporter  gene  only  in  cells  in 
which the endogenous type I collagen genes are active, it is 
difficult to strictly determine from our results whether the 
far-upstream enhancer confers tissue specificity since the 
350-bp proximal proc~2(I) collagen promoter alone can di- 
rect a  low level of tissue-specific expression of reporter 
genes in transgenic mice (Goldberg et al., 1992; Niederrei- 
ther et al.,  1992). However, a high level tissue-specific ex- 
pression was also observed in transgenic embryos contain- 
ing  the  far-upstream  enhancer  placed  5'  of  a  220-bp 
proximal procd(I) collagen promoter. Our previous stud- 
ies  showed  that  in  mice  harboring the  220-bp  proximal 
promoter linked to lacZ, no X-gal staining was  detected 
(Rossert et al.,  1996).  When this promoter was linked to 
the gene for the highly sensitive luciferase enzyme, trans- 
genic mice showed a low level of expression in extracts of 
the skin (Rossert et al.,  1996).  Hence, in mice containing 
the  chimeric  construct,  in  which  the  far-upstream  en- 
hancer of the proa2(I) collagen gene was placed 5' to the 
220-bp proximal procd(I) collagen promoter, it was likely 
that the tissue specificity was directed in large part by the 
upstream enhancer. 
Examination of mice carrying lacZ transgenes driven by 
various promoter lengths of the mouse proal(I) collagen 
gene strongly suggested that separate cis-acting elements 
in this gene controlled expression of reporter genes in dif- 
ferent type I collagen-producing cells (Rossert et al., 1995, 
1996) A similar conclusion was reached in studying the rat 
proal(I) collagen promoter linked to a CAT reporter gene 
(Pavlin et al.,  1992;  Bogdanovic et al.,  1994)  and  also  a 
construction containing a segment of the human pro~xl (I) 
promoter and first intron linked to a growth hormone re- 
porter gene (Liska et al.,  1994). The mouse proa2(I) col- 
lagen gene may be regulated in a similar fashion with sepa- 
rate cis-acting elements driving expression at high levels in 
various cell types. Elements in the minimal promoter and 
Bou-Gharios et al. A Far-Upstream Enhancer in the Mouse Col  l a2 Gene  1343 in the far-upstream enhancer seem to regulate expression 
of reporter genes mainly in fibroblasts and other mesen- 
chymal cells, while elements needed for high levels of ex- 
pression  in  odontoblasts,  endochondral  osteoblasts,  and 
some tendon fibroblasts are lacking. 
In summary, we have identified a potent enhancer ele- 
ment 15 to 17 kb upstream of the mouse pro~2(I) collagen 
gene. We speculate  that this far-upstream  enhancer con- 
trols the expression of the transgene in mesenchymal cells 
such as fibroblasts and some osteoblasts but is not active in 
many osteoblasts or in odontoblasts. Work is in progress 
to better delineate the sequences around HS3 to HS5 that 
support the enhancing activity of this region and to deter- 
mine the transcription factors which bind to this segment 
of DNA. 
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